These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30489687)

  • 21. Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials.
    Koch T; Cassese S; Xhepa E; Mayer K; Tölg R; Hoppmann P; Laugwitz KL; Byrne RA; Kastrati A; Kufner S
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):1008-1015. PubMed ID: 31789486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-eluting balloons in the treatment of de-novo coronary lesions: a meta-analysis of randomized-controlled trials.
    Li Y; Wang C; Zuo G; Wang K; Cao Z; Du X
    Coron Artery Dis; 2016 Sep; 27(6):467-77. PubMed ID: 27100660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous Treatment and Outcomes of Small Coronary Vessels: A SCAAR Report.
    Silverio A; Buccheri S; Venetsanos D; Alfredsson J; Lagerqvist B; Persson J; Witt N; James S; Sarno G
    JACC Cardiovasc Interv; 2020 Apr; 13(7):793-804. PubMed ID: 32061601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial.
    Chen Y; Gao L; Qin Q; Chen S; Zhang J; Chen H; Wang L; Jin Z; Zheng Y; Zhang Z; Li H; Li X; Fu G; Chen L; Sun Z; Wang Y; Jin Q; Cao F; Guo J; Zhao Y; Guan C; Li W; Xu B;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2368-2377. PubMed ID: 30522665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: a comprehensive meta-analysis of 45 randomized trials.
    Verdoia M; Negro F; Kedhi E; Suryapranata H; Marcolongo M; De Luca G
    Vascul Pharmacol; 2021 Jun; 138():106859. PubMed ID: 33819672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Sanz Sánchez J; Chiarito M; Cortese B; Moretti A; Pagnotta P; Reimers B; Stefanini GG; Ferrante G
    Catheter Cardiovasc Interv; 2021 Jul; 98(1):66-75. PubMed ID: 32592437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis.
    Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Mangieri A; Contri R; Stella S; Figini F; Chieffo A; Carlino M; Montorfano M; Colombo A
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1586-94. PubMed ID: 26386758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons.
    Schröder J; Vogt F; Burgmaier M; Reith S; Almalla M
    Coron Artery Dis; 2018 Dec; 29(8):632-637. PubMed ID: 30273183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-Coated Balloons in the Management of Coronary Artery Disease.
    Korjian S; McCarthy KJ; Larnard EA; Cutlip DE; McEntegart MB; Kirtane AJ; Yeh RW
    Circ Cardiovasc Interv; 2024 May; 17(5):e013302. PubMed ID: 38771909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Favorable Angiographic Outcomes After Drug-Coated Balloon Use for de novo Small Vessel Coronary Disease (DCB-ONLY).
    Kang WC; Park SM; Jang AY; Oh PC; Shin ES; Yu CW; Oh SJ; Kim YH; Won H; Lee SR; Lee SY; Hong YJ; Lee SY; Kim BO; Kim SW;
    Angiology; 2021 Nov; 72(10):986-993. PubMed ID: 33982603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Drug-Eluting Balloons for Patients With In-Stent Restenosis: A Meta-Analysis of 8 Randomized Controlled Trials.
    Gao S; Shen J; Mukku VK; Wang MJ; Akhtar M; Liu W
    Angiology; 2016 Aug; 67(7):612-21. PubMed ID: 26483569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis.
    Pleva L; Kukla P; Zapletalova J; Hlinomaz O
    BMC Cardiovasc Disord; 2017 Jun; 17(1):168. PubMed ID: 28651572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials.
    Liu L; Liu B; Ren J; Hui G; Qi C; Wang J
    BMC Cardiovasc Disord; 2018 Mar; 18(1):46. PubMed ID: 29499651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
    Uskela S; Kärkkäinen JM; Eränen J; Siljander A; Mäntylä P; Mustonen J; Rissanen TT
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):893-900. PubMed ID: 30380186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.
    Scheller B; Fontaine T; Mangner N; Hoffmann S; Bonaventura K; Clever YP; Chamie D; Costa R; Gershony G; Kelsch B; Kutschera M; Généreux P; Cremers B; Böhm M; Speck U; Abizaid A
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):51-9. PubMed ID: 26331782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-year follow-up of a randomized multicenter study comparing a drug-coated balloon with a drug-eluting stent in native small coronary vessels: The RESTORE Small Vessel Disease China trial.
    Tian J; Tang YD; Qiao S; Su X; Chen Y; Jin Z; Chen H; Xu B; Kong X; Pang W; Liu Y; Yu Z; Li X; Li H; Zhao Y; Wang Y; Li W; Guan C; Gao R; Xu B;
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():587-597. PubMed ID: 31943693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-Coated Balloon for De Novo Coronary Artery Lesions: A Systematic Review and Trial Sequential Meta-analysis of Randomized Controlled Trials.
    Liu W; Zhang M; Chen G; Li Z; Wei F
    Cardiovasc Ther; 2020; 2020():4158363. PubMed ID: 32934664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-coated balloons for the treatment of in-stent restenosis in diabetic patients: A review of currently available scientific data.
    Minacapelli A; Piraino D; Buccheri D; Cortese B
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):E20-E27. PubMed ID: 28544361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.